Form 4: Accustem Sciences Inc. Director Gabriele M. Cerrone Increases Stake Through Open Market Purchases

Director Gabriele M. Cerrone reports acquiring additional shares of Accustem Sciences Inc. through open market purchases, increasing his indirect holdings.

Summary

• On April 8, 2025, Gabriele M. Cerrone, a director and 10% owner of Accustem Sciences Inc., purchased 35,000 shares of common stock at a price of $0.665 per share.
• On April 9, 2025, Cerrone purchased an additional 3,000 shares of common stock at $0.67 per share.
• These purchases were made indirectly through Panetta Partners Limited.
• Following these transactions, Cerrone's indirect beneficial ownership totals 4,910,759 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The director's increased investment suggests confidence, but it's a routine transaction.

Positives

• A director increasing their stake in the company can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• Shareholders may view the director's stock purchase as a positive signal.

Key Dates

Keywords

Accustem Sciences Inc., ACUT, Gabriele M. Cerrone, Director, 10% Owner, Stock Purchase, Beneficial Ownership, Panetta Partners Limited